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Abstract: Human mitochondrial DNA (mtDNA) is located in discrete DNA-protein 
complexes, so called nucleoids. These structures can be easily visualized in living cells  
by utilizing the fluorescent stain PicoGreen®. In contrary, cells devoid of endogenous 
mitochondrial genomes (ρ0 cells) display no mitochondrial staining in the cytoplasm.  
A modified restriction enzyme can be targeted to mitochondria to cleave the mtDNA 
molecules in more than two fragments, thereby activating endogenous nucleases.  
By applying this novel enzymatic approach to generate mtDNA-depleted cells the 
destruction of mitochondrial nucleoids in cultured cells could be detected in a time course. 
It is clear from these experiments that mtDNA-depleted cells can be seen as early as 48 h 
post-transfection using the depletion system. To prove that mtDNA is degraded during  
this process, mtDNA of transfected cells was quantified by real-time PCR. A significant 
decline could be observed 24 h post-transfection. Combination of both results showed that 
mtDNA of transfected cells is completely degraded and, therefore, ρ0 cells were generated 
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within 48 h. Thus, the application of a mitochondrially-targeted restriction endonuclease 
proves to be a first and fast, but essential step towards a therapy for mtDNA disorders. 
Keywords: mitochondria; mitochondrial DNA (mtDNA); nucleoids; ρ0 cells; restriction 
endonuclease EcoRI; depletion system 
 
1. Introduction 
The energy demand of eukaryotic cells is primarily covered by the ATP production of the oxidative 
phosphorylation system (OXPHOS) that is located in the inner membrane of the mitochondria. 
Genetically, this system is composed of proteins encoded in part by the nuclear and the mitochondrial 
genome. Only the coordinated genetic interplay of the genes of both genomes guarantees the proper 
function of OXPHOS. 
In humans, genetic defects in nuclear or mitochondrial genes are known to cause severe deficiencies 
in oxidative energy supply. It is thought that in these patients the energy demand of the affected  
tissues cannot be solely compensated by the anaerobic energy generated during glycolysis. Ultimately, 
the decreased energy level cannot bolster the vital function of cells and tissues so that energy crisis 
becomes manifested causing a variety of clinical symptoms (e.g., blindness, dementia, autism, myalgia, 
disturbance of equilibrium [1]). 
Giuseppe Attardi’s group introduced first in 1990 a remarkable approach to study mitochondrial 
disorders: by generating cells devoid of endogenous mtDNA (so called ρ0 cells), they were able to  
create a “mitochondrial acceptor” cell line that can be kept alive by applying special culture conditions 
(supplementation of growth media with uridine and pyruvate). These cells were subsequently used in 
fusion experiments with patient’s cytoplasts (cells without nuclei) to study patient’s mitochondria  
in an otherwise “normal” nuclear background of the acceptor cells [2]. 
The pitfall of this system can be identified as the part of the method that is used to generate the 
acceptor cells: by applying ethidium bromide to the growth medium over a period of 4 to 8 weeks, cells 
lose their mtDNA due to a reduced mtDNA replication rate [3]. However, disadvantageous mutagenic 
effects of ethidium bromide and other chemicals were reported (see [4–6] for further details). It cannot 
be excluded that the generation of ρ0 cells via these methods causes changes in the nuclear background, 
thus rendering the ρ0 cell’s nuclear background as potentially mutated. 
To overcome this problem, we recently developed a method that takes advantage of an enzymatic 
approach to generate ρ0 cells: a modified restriction enzyme can be directed into mitochondria to cleave 
the endogenous genomes in more than two fragments depending on the cell’s haplotype background [7]. 
This event would then trigger endogenous mitochondrial nucleases to destroy completely the 
mitochondrial genome (for details see [8,9]). The basis of this system is the vector pMEE-con (depletion 
system with circular DNA). It was shown that the newly developed enzymatic strategy for mtDNA 
depletion is a convenient and suitable tool [8]. A depletion system obtained by PCR amplification of 
pMEE-con (MEE-con-module, depletion system with linear DNA) is also used to verify whether or not 
the structure of the depletion system plays a major role in the localization of EcoRI and the degradation 
of mitochondrial DNA. 
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In human mitochondria, discrete patches of DNA can be visualized by high-resolution electron or 
fluorescence microscopy, utilizing the DNA intercalating dyes ethidium bromide or DAPI as staining 
agents. These so-called nucleoids are made up of copies of the endogenous mitochondrial genome [10] 
as well as a yet not fully identified protein moiety. Most likely, the proteins belong to the mitochondrial 
transcription or replication machinery or take part in the localization of the mtDNA to the inner 
mitochondrial membrane [11–15]. Nucleoids have a uniform mean size of approximately 100 nm in 
mammals and they contain only a single copy of mtDNA (average approximately 1.4 mtDNA molecules 
per nucleoid) [16]. By utilizing Quant-iT™ PicoGreen® [17] in conjunction with the restriction enzyme 
directed to mitochondria (mtDNA depletion system) we were able to visualize for the first time the ρ0 
generation process. Mitochondrial nucleoids were resolved as early as 48 h post-transfection. The 
vanishing of the nucleoids already at that time underlines the extremely rapid mtDNA destruction caused 
by our method to generate ρ0 cells. The decrease of the relative mtDNA amount in a population of 
transfected/non-transfected cells and transfected cells after fluorescence-activated cell sorting was 
confirmed by real-time PCR analysis to further substantiate the qualitative analysis. 
Therefore, ρ0 cells generated by this enzymatic method can definitely improve the utilization of 
cellular models in mitochondrial research. 
2. Results and Discussion 
The enzymatic degradation of mitochondrial DNA with a mitochondrially-targeted restriction 
endonuclease is an important first step towards the replacement of defective mitochondrial genomes and 
thus a genetic therapy. 
It has been clear from previous experiments that the action of the restriction enzyme occurs soon after 
transfection [9]. In the present work we have been able to visualize this process in vivo by confocal 
fluorescence microscopy taking advantage of PicoGreen®, a fluorescent dye known to interact in a highly 
specific manner with DNA [17,18]. 
When cells were stained with PicoGreen®, cytoplasmic nucleoids appeared within the mitochondrial 
network of a cell as units of genetic inheritance [13,19], thereby indicating an uneven focal distribution 
of mtDNA molecules throughout the mitochondrial network. The shape, size and fluorescence intensity 
of the detected nucleoids in our study are consistent with previous findings [20]. Most likely, the 
nucleoids are either directly or indirectly attached to the inner mitochondrial membrane and are 
somehow associated with cytoplasmic tubulin and kinesin [14]. 
In our study we took advantage of the fact that the core structure of the nucleoids is made up of the 
mitochondrial genomes [10]. Hence, the destruction of the mtDNA by our enzymatic approach leads 
ultimately to the breakup of the nucleoid structure. When the number of nucleoids is taken as a rough 
measure for the integrity of mitochondrial DNA, the disappearance of the nucleoids indicates the 
degeneration of the endogenous mitochondrial genomes. 
2.1. Visualization of Mitochondrial DNA Depletion Process 
To visualize mitochondrial DNA depletion combined with the generation of ρ0 cells, microscopic and 
PCR-based methods were applied. The depletion systems pMEE-con and MEE-con-module lead to the 
expression of the restriction endonuclease EcoRI [9]. The import of EcoRI into the mitochondria is 
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achieved with a mitochondrial targeting sequence (see Figure S1). Transfection efficiency and 
localization can be easily analyzed because the attached green fluorescent protein (EGFP) illuminates 
EcoRI paths of action. After transfection with the depletion system the mitochondrial localization of 
EGFP-EcoRI was confirmed. 
We observed that the mitochondrial localization of the fluorescently labeled restriction enzyme is 
associated with the destruction of mtDNA in the transfected cells. This becomes evident by overlaying 
the green EGFP fluorescence with the red staining of mitochondria with the specific dye MitoTracker® 
Red CMXRos (Figures 1 and 2). Transfection with linear and circular depletion system was carried out 
both in 143B.TK− and HEp-2 cells, respectively. 
At 24 h post-transfection the expression of the appropriate PCR product in 143B.TK− cells  
(Figure 1A) lead firstly to an even distribution of EGFP-EcoRI fluorescence within mitochondria. 
Additionally, only few cells showed EGFP fluorescence in distinct sparkles, indicating possible 
destruction sites. 
 
Figure 1. 143B.TK− cells transfected with linear depletion system. 143B.TK− cells were 
transfected with the linear depletion system (MEE-con-module) and analyzed by confocal 
laser scanning microscopy. The EGFP-tagged restriction endonuclease (enhanced green 
fluorescent protein, green color, panels A2–C2) shows a uniform distribution or a punctate 
appearance (“nucleoid” structure) and co-localizes with the MitoTracker® Red CMXRos-stained 
mitochondrial network (red color, panels A1–C1). The superimposition of both colors is 
depicted in the top panel. Images were collected at intervals of 24 h post-transfection. White 
arrows show dissolving mitochondrial network. Calibration marks correspond to 10 µm. 




Figure 2. Detailed images of HEp-2 cells transfected with circular depletion system.  
Cells were transfected with the circular depletion system (pMEE-con with EGFP, green 
color, bottom panels A2–C2) and analyzed by confocal laser scanning microscopy  
at intervals of 24 h post-transfection. The mitochondrial network was stained with 
MitoTracker® Red CMXRos (red color, overlay top panels A1–C1). The punctate 
appearance of the fusion protein EGFP-EcoRI merged into an evenly stained mitochondrial 
network 72 h post-transfection compared to 24 h/48 h, indicating that the interacting partner 
(mtDNA) of the restriction enzyme disappeared. Calibration marks correspond to 2.5 µm. 
At 48 h post-transfection with the linear depletion system (Figure 1B), the mitochondrial matrix was 
not evenly stained. The clear-cut punctate staining differed remarkably from the tubular appearance of 
mitochondria as visualized by MitoTracker® Red CMXRos staining. The superimposition of both images 
(Figure 1B1) underlines this observation, as demonstrated by the yellow sparkle appearance of the 
restriction enzyme in an otherwise red mitochondrial network. This indicates that the fluorescently 
tagged restriction enzyme localizes to distinct regions within the tubular network of mitochondria. 
The observed punctate structure starts to dissolve in some cells into a tubular staining at 72 h  
post-transfection (white arrows), while others remain in a distinct localization within the tubular network 
(see Figure 1, last row). 
The interaction of mitochondrial DNA with endonuclease EcoRI in HEp-2 cells is clearly shown in 
Figure 2, where three time points of the nucleoid structures up to the complete disappearance are 
displayed in detail. 
When cells were transfected with the EGFP-labeled destruction system, an even distribution of the 
fusion enzyme could be seen in the mitochondrial network during the first hours. This is consistent with 
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the assumption that the maturation (folding) of the EcoRI-EGFP fusion protein has to be completed  
before the enzyme can interact with its substrate (see Figure 1A). The image of a detailed HEp-2 cell  
at a higher magnification shows both the even distribution and the punctate structure at 24 h  
post-transfection (Figure 2A). At 48 h post-transfection, nucleoids became more visible indicating, that 
the fusion proteins were mainly associated with their substrates in order to start the cleavage procedure 
of the genomes (Figure 2B). At 72 h the green staining started to disperse throughout the mitochondrial 
network thus overlaying with the MitoTracker® Red staining (Figure 2C). 
The moment of a punctate structure appearance followed by an even distribution depends on different 
factors: the maturation of the protein, the binding of EcoRI to the mtDNA and the utilized cell line.  
In line with our previous finding [9], mtDNA depletion could usually be detected generally as early as 
48 h post-transfection, independently of the used depletion system (circular or linear). 
To further challenge the hypothesis that mtDNA is degraded by the EGFP-EcoRI co-localized with 
the nucleoid structure, transfected cells were stained with the fluorescent dye PicoGreen® that by 
intercalating double stranded DNA visualizes nuclear and mitochondrial DNA [17,18]. The applied 
settings for confocal laser scanning microscopy imaging allowed the preferential detection of the 
nucleoid structure and nuclear staining by PicoGreen® as the EGFP-EcoRI signal is hidden by the 
brightness of PicoGreen® at a similar excitation and emission wave length. 
Therefore, 143B.TK− cells were transfected with the circular depletion system and incubated with 
MitoTracker® Red CMXRos and PicoGreen® dsDNA reagent. As expected, punctate staining indicating 
mitochondrial nucleoids was visualized in most cells at 24 h post initiation process (see Figure 3A,  
first row) with only few individual cells showing exclusively nuclear staining. The number of cells 
without punctate green structures increased over time, indicating that the nucleoid structures dissolve 
(Figure 3A, 48 and 72 h). To highlight these results a control is depicted in Figure S2, cells without 
transfection and incubation time (0 h). Similar data were obtained when transfecting 143B.TK− cells 
with the linear depletion system (MEE-con-module). 
In order to quantify the above observation, more than one hundred 143B.TK− cells (stained with 
MitoTracker® Red CMXRos and PicoGreen®) were counted for each field and analyzed at every time 
point (Figure 3D). After the transfection with the depletion systems, approximately 30% of the cells had 
lost their nucleoid staining after 72 h. 
To further confirm our observations, we stained established ρ0 cell lines with PicoGreen®.  
We analyzed 143B.TK− ρ0 cells, previously generated by transfection with pMEE-con and cloning [9], 
after additional transfection with pMEE-con and MEE-con-module. As expected, the cells displayed 
only nuclear but no cytoplasmic punctate staining (Figure 4). 
Similar results were obtained in HEp-2 ρ0 EtBr cells (generated by incubation with ethidium bromide) 
and HEp-2 ρ0 K1 cells (generated by transfection with pMEE-con). Therefore the absence of 
mitochondrial nucleoids after staining with PicoGreen® is an indicator for ρ0 cells. 
Additionally, it is worth noting that the absence of PicoGreen® stained mitochondrial nucleoids  
in transfected or established ρ0 cells excludes the existence of DNA, either re-ligated or residual  
mtDNA molecules. 
  




Figure 3. Analysis of nucleoid staining in 143B.TK− cells. (A) Confocal images. 143B.TK− 
cells transfected with pMEE-con were analyzed by microscopy. The nucleus and nucleoids 
are stained green (PicoGreen®; panels A2–C2). The mitochondrial network was stained with 
MitoTracker® Red CMXRos and co-localizes with green-stained nucleoids (panels A1–C1, 
overlay). A few cells do not show nucleoid staining (indicating ρ0 status). Calibration marks 
correspond to 10 µm; (D) Quantification of images. More than one hundred 143B.TK− cells 
were counted and analyzed. The diagram shows the percentage of cells without nucleoid 
staining after transfection with various depletion systems. Bars describe the arithmetic  
mean ± SD. ** p < 0.01, *** p < 0.001. 




Figure 4. The 143B.TK− ρ0 K7 cells transfected with depletion systems. The 143B.TK− ρ0 
K7 cells were transfected with pMEE-con (A) and MEE-con-module (B) and analyzed  
24 h post-transfection by confocal laser scanning microscopy. Cells were incubated with 
PicoGreen® (green color, panel A2,B2) to stain DNA. The mitochondrial network was stained 
with MitoTracker® Red CMXRos (red color, panel A3,B3). Overlay of both fluorescent 
stainings are depicted in panel A1 and B1. Calibration marks correspond to 10 µm. 
2.2. Quantitative Analysis of Mitochondrial DNA 
To challenge the hypothesis that mtDNA is fully depleted by endogenous nucleases after transfection 
with our kit, a quantitative analysis of mtDNA in a transfected cell population was performed by  
real-time PCR. As shown in Figure 5, the relative amount of mtDNA (ND1 or ND5 genes) vs. nuclear 
DNA (18S ribosomal gene) was measured using different primer pairs both in 143B.TK− and HEp-2 
cells. The amplification of nuclear mitochondrial DNA fragments was largely excluded (see Supplementary 
Materials Section 2, Figure S3) [21–26]. 
Firstly, to rule out any negative effect of the transfection procedure and/or of the recombinant protein 
expression on mitochondrial DNA content, cells were transfected with a construct for the expression  
of mitochondrially targeted EGFP without nucleolytic activity (pEGFP-Mito). Transfected cells did  
not show any significant variation of mtDNA content (Figure 5A,C, gray bars), thus excluding any 
unspecific effect by the experimental procedures on mtDNA content. The transfection efficiency 48 h 
post-transfection was approximately 45% for 143B.TK− cells and 60% for HEp-2 cells, respectively. 
Next, cells were transfected with the depletion systems and the DNA was quantified utilizing  
real-time PCR to prove that mtDNA is degraded after transfection. 
  




Figure 5. Relative quantification of mtDNA in transfected cells. Cells were harvested 
directly before (0 h) or 24 h/48 h post-transfection with pEGFP-Mito (transfection control), 
circular depletion system (pMEE-con) or linear depletion system (MEE-con-module). 
Furthermore, non-transfected cells were used as control. Experiments were performed in 
triplicate. Data are expressed as ratio between mitochondrial DNA (ND1 or ND5 gene) vs. 
nuclear (ribosomal 18S gene) DNA content. Bars represent the mean ± SD. * p < 0.05,  
** p < 0.01, *** p < 0.001. (A) 143B.TK− cells; (B) 143B.TK− cells transfected with 
depletion system (pMEE-con). Relative mtDNA content of DNA isolates was analyzed using 
ND1 (04094–04175 bp) and ND5 (13,893–13,983 bp) gene as targets in real-time PCR. 
Amplified target sequences differ in encompassing a recognition site for the restriction 
endonuclease EcoRI; (C) HEp-2 cells; (D) HEp-2 transfected cells. EGFP expressing cells 
were separated from non-transfected cells by fluorescence-activated cell sorting. 
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As expected, a significant reduction of relative mtDNA content in 143B.TK− cells was observed  
24 h post-transfection with the depletion kit: the total mtDNA amount was reduced by 25% (pMEE-con) 
and 40% (MEE-con-module) (see Figure 5A). At 48 h post-transfection with the circular depletion kit, 
the observed 55% reduction of mtDNA was in line with the 45% transfection efficiency, thus suggesting 
that total loss of mtDNA occurred in transfected cells. Interestingly, the data also show that the mtDNA 
depletion is less effective when using the linearized pMEE-con transfection (Figure 5A, light gray bars). 
Again, the mtDNA decrease (30%) was consistent with the transfection efficiency (30%) thus pointing 
to a lower uptake of linearized DNA during transfection [27]. Furthermore, the presence of a similar 
mtDNA content 24 and 48 h post-transfection with the linear depletion system could be explained by the 
lack of origin of replication and the consequent dilution of the construct during cell division. These 
findings were confirmed by the results obtained with the HEp-2 cell line (Figure 5C, light gray bars). 
To exclude the contribution of non-transfected cells in the quantitative analysis, a fluorescence-activated 
cell sorting was used to separate the two populations of cells based on the expression of the EGFP fusion 
protein. HEp-2 cells transfected with the circular depletion system were sorted by flow cytometry and 
mtDNA content was measured by quantitative real-time PCR (Figure 5D). In comparison to non-transfected 
parental cells the mtDNA content in sorted cells was drastically decreased to 7% and 5% at 24 and 48 h 
post-transfection showing that the circular depletion vector could reach its maximum efficiency already 
at 24 h post-transfection. 
Specific destruction of mtDNA mutated molecules associated with mitochondrial diseases has been 
proposed to be a potential therapy for mitochondrial diseases caused by mutations that create a unique 
restriction endonuclease cleavage site in the mtDNA [28,29]. In contrast to these studies we offer  
with other methods a more rapid destruction of total mtDNA with the restriction endonuclease EcoRI  
to generate ρ0 cells, as EcoRI creates three to five destruction start sites, depending on the mtDNA 
background. However, it is well understood that a repopulation with intact mitochondrial genomes is an 
essentially required second step when thinking of a genetic therapy (patent pending, [30]). 
With our depletion strategy, after cleavage of mtDNA, endogenous nucleolytic enzymes start to 
degrade DNA at the generated 5'- and 3'-endings. To distinguish the cleaving and degrading process of 
mtDNA in 143B.TK− cells after expression of mitochondrially targeted EGFP-EcoRI, mtDNA depletion 
was assessed using two different primer sets. The first set hybridized to the mitochondrial ND1 gene 
thereby encompassing an EcoRI restriction site. Hence, only un-cleaved mtDNA molecules would be 
amplified (Figure 5B, dark gray bars). A second primer set, hybridizing to the mitochondrial ND5 gene 
that does not contain an EcoRI recognition site was taken. This set can amplify mtDNA that is cleaved 
but not completely degraded by endogenous enzymes (Figure 5B, light gray bars). The data show that 
both mtDNA species can be amplified to a similar extent in a transfected cell population over a period 
of 48 h, thus suggesting that degradation of mtDNA by endogenous nucleases occurs soon after cleavage. 
3. Experimental Section 
3.1. DNA 
The plasmid pMEE-con is a fusion gene product consisting of the endonuclease EcoRI gene and  
a mitochondrial targeting sequence derived from the human cytochrome c oxidase subunit 8 (please see 
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Figure S1 and [9] for details). After transfection and constitutive expression of restriction endonuclease 
EcoRI, the EGFP green fluorescent marker could monitor the mitochondrial localization of the fusion 
protein. The circular depletion vector (pMEE-con) was used directly for transfection experiments and as 
template for PCR utilizing the following primers: pEGFP-N1-1868-REV 5'-GGGCCATCGCCCTGATAG-3' 
and pTRE2hyg-2364-REV 5'-AGTTAGGCCACCACTTCAAGAACTCT-3'. In addition to this experiment, 
the PCR-product was used for transfection as linear depletion system (MEE-con-module). 
The control vector pEGFP-Mito leads to the expression of a mitochondrially targeted EGFP. 
3.2. Cell Culture 
Human osteosarcoma cells 143B.TK− (ATCC CRL-8303) were grown in high glucose Dulbecco’s 
modified Eagle’s medium (DMEM, with stable glutamine and pyruvate) supplemented with 10% (v/v) 
fetal calf serum (FCS) and 100 μg/mL bromodeoxyuridine (BrdU), at 37 °C in a humidified atmosphere 
containing 5% CO2. 
Human larynx carcinoma cells HEp-2 (ATCC CCL-23) were cultured under standard conditions  
(37 °C, 5% CO2) in DMEM (high glucose, with stable glutamine and pyruvate) supplemented with 10% 
(v/v) FCS and 100 µM non-essential amino acids. 
The ρ0 cell lines 143B.TK− ρ0 K7 and HEp-2 ρ0 K1 were generated by transfection of wild  
type cells with pMEE-con (as described in [9]). The ρ0 cell line referred to as 143B.TK− ρ0 EtBr and 
HEp-2 ρ0 EtBr were generated by incubation of wild type cells with low doses of ethidium bromide  
(as described in [3]). The ρ0 cell lines were maintained as indicated with additional supplementation of 
50 µg/mL uridine. 
3.3. Transfection and Labeling of Cells 
For microscopic analysis, live cells were cultured for one day on glass bottom dishes (MatTek 
Corporation, Ashland, MA, USA). Transient transfection with circular (vector pMEE-con) and linear 
depletion system (MEE-con-module) were performed using TransIT®-LT1 (Mirus, Madison, WI, USA) 
according to the manufacturer’s conditions. The transfected cells were cultured in media supplemented 
with uridine. 
Cells were stained with MitoTracker® Red CMXRos (Invitrogen, Molecular Probes, Karlsruhe, 
Germany) for mitochondrial network analysis. To stain nucleus and nucleoids, the cells were incubated 
with Quant-iT™ PicoGreen® dsDNA reagent (Invitrogen) as described elsewhere [17]. 
For real-time PCR analysis the cells were cultured for one day on 35 mm culture dishes (TPP, Techno 
Plastic Products AG, Trasadingen, Switzerland) and subsequently were transfected as described before. 
An additional transfection control was carried out using a vector construct that leads to the expression 
of mitochondrially targeted EGFP (pEGFP-Mito). 
3.4. Confocal Microscopy 
The cells were analyzed with an inverted confocal laser scanning microscope TCS SP5 (Leica 
Microsystems, Wetzlar, Germany) after 24, 48 and 72 h of cultivation. 
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To avoid a cross talk in excitation of 488 and 561 nm multiple stained compounds, a sequential 
scanning mode was executed. Images were acquired with photomultipliers and micrographs were 
processed and analyzed with the software Leica Application Suite Advanced Fluorescence 2.6.0 (Leica 
Microsystems, Wetzlar, Germany), Adobe Photoshop CS (Adobe Systems, Munich, Germany), ImageJ 
1.45s (NIH, Bethesda, MD, USA) and Huygens Professional 4.2.1 (SVI, Hilversum, The Netherlands). 
3.5. Fluorescence-Activated Cell Sorting (FACS) 
Transfected cells at each time point were sorted by flow cytometry (FACSAria SORP–cell sorter, BD 
Biosciences, Heidelberg, Germany). To detect the green fluorescent cells an argon-laser with 488 nm 
(TCS SP5 Leica Microsystems, Wetzlar, Germany) was utilized. The efficiency averaged over 95%. 
Harvested cells were directly processed for DNA isolation or stored at −20 °C. 
3.6. Real-Time PCR 
The loss of endogenous mitochondrial DNA (mtDNA) after transfection with the depletion systems 
was controlled by quantitative real-time PCR. Therefore, genomic DNA (nDNA) of parental, transfected 
and sorted cells were isolated via phenol/chloroform extraction at different time points after transfection 
(0, 24 and 48 h). Relative quantification of mtDNA and nDNA was carried out employing a 7500  
real-time PCR system from Applied Biosystems (Weiterstadt, Germany), software SDS V1.2.3 and the 
qPCR MasterMix Plus for SYBR® Green I Low ROX (Eurogentec, Seraing, Belgium). As endogenous 
control the 18S gene was used (18S-1036-FW 5'-AGTCGGAGGTTCGAAGACGAT-3' and  
18S-1127-REV 5'-GCGGGTCATGGGAATAACG-3'). The mitochondrial target gene ND1 (04094-FW 
5'-CCCTACTTCTAACCTCCCTGTTCTTAT-3' and 04175-REV 5'-CATAGGAGGTGTATGAGTT 
GGTCGTA-3', flanking an EcoRI recognition site) or the mitochondrial ND5 gene (13893-FW 5'-ATT 
TTATTTCTCCAACATACTCGGATT-3' and 13983-REV 5'-GGGCAGGTTTTGGCTCGTA-3') were 
utilized for the relative evaluation of mtDNA compared to nDNA of cells post-transfection. 
The analysis of mtDNA in ρ0 cells and parental cell lines was carried out by quantitative real-time 
PCR (Supplementary Materials) after isolation of DNA (software SDS V1.5.1). In this case the Takyon 
Low ROX SYBR MasterMix blue dTTP (Eurogentec, Seraing, Belgium) was used because of 
manufacturer’s conversion. Different endogenous controls were employed: 18S gene (18S-1036-FW  
and 18S-1127-REV); β-Actin gene (ACTB-617-FW 5'-GGGAAATCGTGCGTGACATTA-3' and 
ACTB-762-REV 5'-CCGCTCATTGCCAATGGT-3') and COX6A1 gene (COX6A1-099-FW  
5'-CTCAGCTCGCATGTGGAAGA-3' and COX6A1-244-REV5'-TGGTCCTGATGCGGAGATG-3').  
To detect mtDNA fragments following primer sets were used: ND1 (03497-FW 5'-CCACA 
TCTACCATCACCCTC-3' and 03565-REV 5'-TTCATAGTAGAAGAGCGATGGT-3', without  
EcoRI recognition site), ND1 (04094-FW and 04175-REV, encompass EcoRI recognition site);  
ND2 (04841-FW 5'-GACATCCGGCCTGCTTCTT-3' and 04922-REV 5'-TACGTTTAGTGAGG 
GAGAGATTTGG-3'); ND5 (12574-FW 5'-TTCAAACTAGACTACTTCTCCATAATATTCATC-3' 
and 12674-REV 5'-TTGGGTCTGAGTTTATATATCACAGTGA-3', containing EcoRI recognition site) 
and ND5 (13893-FW and 13983-REV, without EcoRI recognition site). 
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3.7. Statistical Analysis 
Data of relative mtDNA quantification are shown as mean ± standard deviation (SD) of two or three 
identical experiments performed in triplicate. To analyze the statistically significant differences between 
non-transfected and transfected cells an unpaired two-sample t-test was rendered applying software 
SigmaPlot version 12.0 (Systat Software, Erkrath, Germany). Differences were designated significant  
at values * p < 0.05, highly significant at ** p < 0.01 and very highly significant at *** p < 0.001 and 
were labeled with asterisks. 
The qualitative changes of cells with or without nucleoids were counted using the acquired confocal 
images. A minimum of one hundred cells per sample was counted. Because an average of only two 
values was analyzed, statistical significance could not be determined. 
4. Conclusions 
In this study we demonstrated for the first time that the action of the mitochondrial DNA depletion 
system is immediate. We shed light on the time line of the process of mtDNA degradation by confocal 
fluorescence microscopy and furthermore by real-time PCR of mixed (transfected and non-transfected) 
and sorted cells, respectively. 
The destruction of mitochondrial DNA can be easily followed by the disappearance of mitochondrial 
nucleoids. The time required to completely dissolve the mitochondrial nucleoids and thus the 
mitochondrial genomes can vary in a cell type as well as in an individual cell dependent manner. These 
experiments indicate that mtDNA depleted cells can be seen as early as 48 h post-transfection. A total 
of approximately 30% of nucleoids depleted cells in a transfected cell population were seen at 72 h post 
initiation process. 
The cleavage of mtDNA was quantified by real-time PCR. The experiments could depict that  
cleaved mtDNA is subsequently degraded within 24 to 48 h post-transfection in different cell lines and 
with both depletion systems. Cell quantification after transfection and sorting reveals a drastic reduction 
of mtDNA content below 10%. Consequently the efficiency of the depletion system can be as high as 
90% (depending on the cell line used). 
Both technologies used to analyze the process of mtDNA degradation, confocal microscopy and  
real-time PCR, complement one another. Thus, the developed technology with the restriction 
endonuclease EcoRI allows a mild and very fast strategy to deplete endogenous genomes from cells so 
that these cells can be easily utilized in human cytogenetic experiments and diagnostics. 
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